XML 30 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
Note 14 - Business Segments
6 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]

14.

BUSINESS SEGMENTS

 

The Company operated in four segments: the testing service industry (which performs structural and electronic tests of semiconductor devices); the designing and manufacturing of equipment (assembly of equipment that tests the structural integrity of integrated circuits and other products); distribution of various products from other manufacturers in Singapore and Asia; and the real estate segment in China.

 

The cost of equipment, current year investment in new equipment and depreciation expense are allocated into respective segments based on the primary purpose for which the equipment was acquired.

 

Corporate expenses are allocated to the four segments on a combination of factors involving revenue, manpower costs and fixed assets investments, except the Malaysia and China operations, which is calculated based on actual sales. The following segment information table includes segment operating income or loss after including corporate expense allocated to the segments, which gets eliminated in the consolidation.

 

The following segment Information is unaudited for the six months ended December 31, 2023, and December 31, 2022:

 

Business Segment Information:

 

Six Months

         

Operating

                         
 

Ended

 

Net

   

Income /

   

Total

   

Depr. And

   

Capital

 
 

Dec. 31,

 

Revenue

   

(Loss)

   

Assets

   

Amort.

   

Expenditures

 

Manufacturing

2023

  $ 7,675     $ 149    

$

19,242     $ 214     $ 38  
 

2022

  $ 8,629     $ 477     $ 15,345     $ 230     $ 15  
                                           

Testing Services

2023

    9,810       (280

)

    22,690       2,507       120  
 

2022

    12,012       1,129       27,757       1,875       3,967  
                                           

Distribution

2023

    4,670       646       1,976       -       -  
 

2022

    3,676       482       1,437       -       -  
                                           

Real Estate

2023

    13       (53

)

    2,502       36       -  
 

2022

    12       (42

)

    1,580       38       -  
                                           

Corporate & Unallocated

2023

    -       214       188       27       -  
 

2022

    -       90       77       -       12  
                                           

Total Company

2023

  $ 22,168     $ 676    

$

46,598     $ 2,784     $ 158  
 

2022

  $ 24,329     $ 2,136     $ 46,196     $ 2,143     $ 3,994  

 

The following segment Information is unaudited for the three months ended December 31, 2023, and December 31, 2022:

 

Business Segment Information:

 

Three Months

         

Operating

                         
 

Ended

 

Net

   

Income /

   

Total

   

Depr. And

   

Capital

 
 

Dec. 31,

 

Revenue

   

(Loss)

   

Assets

   

Amort.

   

Expenditures

 

Manufacturing

2023

  $ 4,790     $ 191    

$

19,242     $ 101     $ 19  
 

2022

  $ 5,044     $ 301     $ 15,345     $ 99     $ 15  
                                           

Testing Services

2023

    4,646       (152

)

    22,690       1,181       62  
 

2022

    5,648       547       27,757       1,111       2,811  
                                           

Distribution

2023

    2,760       401       1,976       -       -  
 

2022

    1,694       217       1,437       -       -  
                                           

Real Estate

2023

    6       (27

)

    2,502       18       -  
 

2022

    4       (28

)

    1,580       20       -  
                                           

Corporate & Unallocated

2023

            264       188       15       -  
 

2022

    -       32       77       6       12  
                                           

Total Company

2023

  $ 12,202     $ 677    

$

46,598     $ 1,315     $ 81  
 

2022

  $ 12,390     $ 1,069     $ 46,196     $ 1,236     $ 2,838  

 

 

Management is currently evaluating the ongoing contributions of each of its business segments to its current and future revenue and prospects, including its testing segment. As a result, it may divest one or more business segments in the future, including its testing segment, to enable management to concentrate on segments where it anticipates opportunities for future revenue growth, thereby maximizing shareholder value.